Showing results (11-20 of 322) with videos related to
Sort By:
Pageof 33
Journal of Medicinal Chemistry|March 17, 2012
Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A)Clara C Blad, Jacobus P D van Veldhoven, Corné Klopman, et al.Biochemical Pharmacology|February 28, 2016
Human G protein-coupled receptor studies in Saccharomyces cerevisiaeRongfang Liu, Winsy Wong, Adriaan P IJzermanBioinformatics (Oxford, England)|February 29, 2008
Tracing evolutionary pressureKai Ye, Gert Vriend, Adriaan P IJzermanJournal of Medicinal Chemistry|January 26, 2010
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonistsVsevolod Katritch, Veli-Pekka Jaakola, J Robert Lane, et al.Medicinal Research Reviews|January 24, 2007
Nicotinic acid receptor subtypes and their ligandsWillem Soudijn, Ineke van Wijngaarden, Adriaan P IjzermanBritish Journal of Pharmacology|August 11, 2004
Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activationYolande Cordeaux, Adriaan P Ijzerman, Stephen J HillMedicinal Research Reviews|April 9, 2005
Structure-activity relationships of inverse agonists for G-protein-coupled receptorsWillem Soudijn, Ineke van Wijngaarden, Adriaan P IjzermanChemmedchem|October 28, 2015
The Role of Target Binding Kinetics in Drug DiscoveryDong Guo, Laura H Heitman, Adriaan P IJzermanChemical Reviews|April 19, 2016
Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine ReceptorsDong Guo, Laura H Heitman, Adriaan P IJzermanACS Medicinal Chemistry Letters|September 24, 2016
The Added Value of Assessing Ligand-Receptor Binding Kinetics in Drug DiscoveryDong Guo, Laura H Heitman, Adriaan P IJzermanPageof 33